NextPlat Corp. (NASDAQ:NXPL – Get Free Report) was the recipient of a large decrease in short interest in the month of June. As of June 30th, there was short interest totaling 7,645 shares, a decrease of 36.1% from the June 15th total of 11,956 shares. Based on an average daily volume of 40,854 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.5% of the shares of the company are sold short.
Analyst Upgrades and Downgrades
A number of equities analysts recently weighed in on the stock. Weiss Ratings raised shares of NextPlat from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, May 11th. Litchfield Hills Research started coverage on shares of NextPlat in a research report on Wednesday, June 24th. They issued a “buy” rating and a $11.00 price objective on the stock. Finally, Zacks Research upgraded shares of NextPlat to a “hold” rating in a research note on Thursday, June 25th. One research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $11.00.
Institutional Trading of NextPlat
NextPlat Stock Down 4.1%
NXPL stock opened at $5.81 on Friday. The company has a debt-to-equity ratio of 0.05, a quick ratio of 2.12 and a current ratio of 2.56. The company has a market capitalization of $15.75 million, a price-to-earnings ratio of -1.34 and a beta of 1.87. NextPlat has a fifty-two week low of $3.38 and a fifty-two week high of $11.10. The stock has a fifty day moving average of $6.51 and a 200-day moving average of $5.98.
NextPlat (NASDAQ:NXPL – Get Free Report) last announced its quarterly earnings data on Thursday, May 14th. The company reported ($0.42) earnings per share for the quarter. NextPlat had a negative return on equity of 58.05% and a negative net margin of 23.14%.The firm had revenue of $9.86 million during the quarter. As a group, equities research analysts predict that NextPlat will post -0.55 earnings per share for the current year.
About NextPlat
NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.
See Also
- Five stocks we like better than NextPlat
- MarketBeat Week in Review – 07/13- 07/17
- AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector
- Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth
- TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident
Receive News & Ratings for NextPlat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextPlat and related companies with MarketBeat.com's FREE daily email newsletter.
